The Agency for Medical Research (ABM) is launching a competition for non-commercial clinical trials and research experiments in the field of oncology, allocating PLN 600 million for projects aimed at changing cancer diagnosis and therapy in Poland.
The World Health Organization (WHO) has indicated that cancer is one of the leading causes of death worldwide. In Poland, the situation is alarming; by 2025, cancer could become the leading cause of death for Poles. According to forecasts by the Maria Sklodowska-Curie National Institute of Oncology, cancer mortality in Poland is 15% higher than the EU average, and the COVID-19 pandemic has caused a significant drop in the number of diagnosed cases. In the face of these challenges, support for this therapeutic area, by incre...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
